nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—CYP1A2—Anastrozole—breast cancer	0.143	0.401	CbGbCtD
Frovatriptan—CYP1A2—Toremifene—breast cancer	0.13	0.367	CbGbCtD
Frovatriptan—CYP1A2—Tamoxifen—breast cancer	0.0476	0.134	CbGbCtD
Frovatriptan—CYP1A2—Fluorouracil—breast cancer	0.0351	0.0987	CbGbCtD
Frovatriptan—Shock—Docetaxel—breast cancer	0.000139	0.000267	CcSEcCtD
Frovatriptan—Pruritus—Fluorouracil—breast cancer	0.000139	0.000266	CcSEcCtD
Frovatriptan—Visual impairment—Methotrexate—breast cancer	0.000138	0.000265	CcSEcCtD
Frovatriptan—Confusional state—Capecitabine—breast cancer	0.000138	0.000265	CcSEcCtD
Frovatriptan—Tachycardia—Docetaxel—breast cancer	0.000138	0.000265	CcSEcCtD
Frovatriptan—Feeling abnormal—Paclitaxel—breast cancer	0.000138	0.000264	CcSEcCtD
Frovatriptan—Bradycardia—Epirubicin—breast cancer	0.000137	0.000262	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Paclitaxel—breast cancer	0.000137	0.000262	CcSEcCtD
Frovatriptan—Diarrhoea—Gemcitabine—breast cancer	0.000137	0.000262	CcSEcCtD
Frovatriptan—Dizziness—Irinotecan—breast cancer	0.000135	0.00026	CcSEcCtD
Frovatriptan—Haemoglobin—Epirubicin—breast cancer	0.000135	0.000259	CcSEcCtD
Frovatriptan—Stomatitis—Doxorubicin—breast cancer	0.000135	0.000259	CcSEcCtD
Frovatriptan—Anorexia—Docetaxel—breast cancer	0.000135	0.000259	CcSEcCtD
Frovatriptan—Shock—Capecitabine—breast cancer	0.000135	0.000258	CcSEcCtD
Frovatriptan—Rhinitis—Epirubicin—breast cancer	0.000135	0.000258	CcSEcCtD
Frovatriptan—Conjunctivitis—Doxorubicin—breast cancer	0.000135	0.000258	CcSEcCtD
Frovatriptan—Haemorrhage—Epirubicin—breast cancer	0.000134	0.000258	CcSEcCtD
Frovatriptan—Diarrhoea—Fluorouracil—breast cancer	0.000134	0.000257	CcSEcCtD
Frovatriptan—Tinnitus—Methotrexate—breast cancer	0.000134	0.000257	CcSEcCtD
Frovatriptan—Tachycardia—Capecitabine—breast cancer	0.000134	0.000256	CcSEcCtD
Frovatriptan—Hypoaesthesia—Epirubicin—breast cancer	0.000134	0.000256	CcSEcCtD
Frovatriptan—Pharyngitis—Epirubicin—breast cancer	0.000133	0.000256	CcSEcCtD
Frovatriptan—Urinary tract disorder—Epirubicin—breast cancer	0.000133	0.000254	CcSEcCtD
Frovatriptan—Hyperhidrosis—Capecitabine—breast cancer	0.000133	0.000254	CcSEcCtD
Frovatriptan—Abdominal pain—Paclitaxel—breast cancer	0.000132	0.000253	CcSEcCtD
Frovatriptan—Body temperature increased—Paclitaxel—breast cancer	0.000132	0.000253	CcSEcCtD
Frovatriptan—Urethral disorder—Epirubicin—breast cancer	0.000132	0.000252	CcSEcCtD
Frovatriptan—Epistaxis—Doxorubicin—breast cancer	0.000131	0.00025	CcSEcCtD
Frovatriptan—Anorexia—Capecitabine—breast cancer	0.000131	0.00025	CcSEcCtD
Frovatriptan—Vomiting—Mitoxantrone—breast cancer	0.00013	0.00025	CcSEcCtD
Frovatriptan—Vomiting—Irinotecan—breast cancer	0.00013	0.00025	CcSEcCtD
Frovatriptan—Sinusitis—Doxorubicin—breast cancer	0.00013	0.000249	CcSEcCtD
Frovatriptan—Dizziness—Fluorouracil—breast cancer	0.00013	0.000249	CcSEcCtD
Frovatriptan—Visual impairment—Epirubicin—breast cancer	0.00013	0.000248	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000129	0.000247	CcSEcCtD
Frovatriptan—Chills—Methotrexate—breast cancer	0.000129	0.000247	CcSEcCtD
Frovatriptan—Headache—Mitoxantrone—breast cancer	0.000128	0.000246	CcSEcCtD
Frovatriptan—Headache—Irinotecan—breast cancer	0.000128	0.000246	CcSEcCtD
Frovatriptan—Insomnia—Docetaxel—breast cancer	0.000128	0.000245	CcSEcCtD
Frovatriptan—Paraesthesia—Docetaxel—breast cancer	0.000127	0.000244	CcSEcCtD
Frovatriptan—Vomiting—Gemcitabine—breast cancer	0.000127	0.000243	CcSEcCtD
Frovatriptan—Bradycardia—Doxorubicin—breast cancer	0.000127	0.000243	CcSEcCtD
Frovatriptan—Dyspnoea—Docetaxel—breast cancer	0.000126	0.000242	CcSEcCtD
Frovatriptan—Somnolence—Docetaxel—breast cancer	0.000126	0.000241	CcSEcCtD
Frovatriptan—Mental disorder—Methotrexate—breast cancer	0.000126	0.000241	CcSEcCtD
Frovatriptan—Tinnitus—Epirubicin—breast cancer	0.000125	0.00024	CcSEcCtD
Frovatriptan—Malnutrition—Methotrexate—breast cancer	0.000125	0.00024	CcSEcCtD
Frovatriptan—Haemoglobin—Doxorubicin—breast cancer	0.000125	0.00024	CcSEcCtD
Frovatriptan—Headache—Gemcitabine—breast cancer	0.000125	0.000239	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000125	0.000239	CcSEcCtD
Frovatriptan—Flushing—Epirubicin—breast cancer	0.000125	0.000239	CcSEcCtD
Frovatriptan—Vomiting—Fluorouracil—breast cancer	0.000125	0.000239	CcSEcCtD
Frovatriptan—Rhinitis—Doxorubicin—breast cancer	0.000125	0.000239	CcSEcCtD
Frovatriptan—Dyspepsia—Docetaxel—breast cancer	0.000125	0.000239	CcSEcCtD
Frovatriptan—Haemorrhage—Doxorubicin—breast cancer	0.000124	0.000238	CcSEcCtD
Frovatriptan—Insomnia—Capecitabine—breast cancer	0.000124	0.000238	CcSEcCtD
Frovatriptan—Hypoaesthesia—Doxorubicin—breast cancer	0.000124	0.000237	CcSEcCtD
Frovatriptan—Pharyngitis—Doxorubicin—breast cancer	0.000123	0.000237	CcSEcCtD
Frovatriptan—Paraesthesia—Capecitabine—breast cancer	0.000123	0.000236	CcSEcCtD
Frovatriptan—Decreased appetite—Docetaxel—breast cancer	0.000123	0.000236	CcSEcCtD
Frovatriptan—Hypersensitivity—Paclitaxel—breast cancer	0.000123	0.000236	CcSEcCtD
Frovatriptan—Headache—Fluorouracil—breast cancer	0.000123	0.000235	CcSEcCtD
Frovatriptan—Urinary tract disorder—Doxorubicin—breast cancer	0.000123	0.000235	CcSEcCtD
Frovatriptan—Dysgeusia—Methotrexate—breast cancer	0.000122	0.000235	CcSEcCtD
Frovatriptan—Dyspnoea—Capecitabine—breast cancer	0.000122	0.000234	CcSEcCtD
Frovatriptan—Fatigue—Docetaxel—breast cancer	0.000122	0.000234	CcSEcCtD
Frovatriptan—Urethral disorder—Doxorubicin—breast cancer	0.000122	0.000234	CcSEcCtD
Frovatriptan—Nausea—Mitoxantrone—breast cancer	0.000122	0.000233	CcSEcCtD
Frovatriptan—Nausea—Irinotecan—breast cancer	0.000122	0.000233	CcSEcCtD
Frovatriptan—Pain—Docetaxel—breast cancer	0.000121	0.000232	CcSEcCtD
Frovatriptan—Constipation—Docetaxel—breast cancer	0.000121	0.000232	CcSEcCtD
Frovatriptan—Back pain—Methotrexate—breast cancer	0.000121	0.000232	CcSEcCtD
Frovatriptan—Dyspepsia—Capecitabine—breast cancer	0.000121	0.000231	CcSEcCtD
Frovatriptan—Chills—Epirubicin—breast cancer	0.000121	0.000231	CcSEcCtD
Frovatriptan—Arrhythmia—Epirubicin—breast cancer	0.00012	0.00023	CcSEcCtD
Frovatriptan—Visual impairment—Doxorubicin—breast cancer	0.00012	0.00023	CcSEcCtD
Frovatriptan—Asthenia—Paclitaxel—breast cancer	0.00012	0.00023	CcSEcCtD
Frovatriptan—Decreased appetite—Capecitabine—breast cancer	0.000119	0.000228	CcSEcCtD
Frovatriptan—Nausea—Gemcitabine—breast cancer	0.000119	0.000227	CcSEcCtD
Frovatriptan—Fatigue—Capecitabine—breast cancer	0.000118	0.000226	CcSEcCtD
Frovatriptan—Pruritus—Paclitaxel—breast cancer	0.000118	0.000226	CcSEcCtD
Frovatriptan—Mental disorder—Epirubicin—breast cancer	0.000118	0.000226	CcSEcCtD
Frovatriptan—Pain—Capecitabine—breast cancer	0.000117	0.000225	CcSEcCtD
Frovatriptan—Constipation—Capecitabine—breast cancer	0.000117	0.000225	CcSEcCtD
Frovatriptan—Malnutrition—Epirubicin—breast cancer	0.000117	0.000224	CcSEcCtD
Frovatriptan—Feeling abnormal—Docetaxel—breast cancer	0.000117	0.000224	CcSEcCtD
Frovatriptan—Nausea—Fluorouracil—breast cancer	0.000117	0.000223	CcSEcCtD
Frovatriptan—Ill-defined disorder—Methotrexate—breast cancer	0.000116	0.000222	CcSEcCtD
Frovatriptan—Tinnitus—Doxorubicin—breast cancer	0.000116	0.000222	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Docetaxel—breast cancer	0.000116	0.000222	CcSEcCtD
Frovatriptan—Flushing—Doxorubicin—breast cancer	0.000115	0.000221	CcSEcCtD
Frovatriptan—Flatulence—Epirubicin—breast cancer	0.000115	0.000221	CcSEcCtD
Frovatriptan—Tension—Epirubicin—breast cancer	0.000115	0.00022	CcSEcCtD
Frovatriptan—Dysgeusia—Epirubicin—breast cancer	0.000115	0.00022	CcSEcCtD
Frovatriptan—Diarrhoea—Paclitaxel—breast cancer	0.000114	0.000219	CcSEcCtD
Frovatriptan—Nervousness—Epirubicin—breast cancer	0.000114	0.000218	CcSEcCtD
Frovatriptan—Back pain—Epirubicin—breast cancer	0.000113	0.000217	CcSEcCtD
Frovatriptan—Feeling abnormal—Capecitabine—breast cancer	0.000113	0.000216	CcSEcCtD
Frovatriptan—Malaise—Methotrexate—breast cancer	0.000113	0.000216	CcSEcCtD
Frovatriptan—Muscle spasms—Epirubicin—breast cancer	0.000113	0.000216	CcSEcCtD
Frovatriptan—Vertigo—Methotrexate—breast cancer	0.000112	0.000215	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Capecitabine—breast cancer	0.000112	0.000215	CcSEcCtD
Frovatriptan—Body temperature increased—Docetaxel—breast cancer	0.000112	0.000214	CcSEcCtD
Frovatriptan—Abdominal pain—Docetaxel—breast cancer	0.000112	0.000214	CcSEcCtD
Frovatriptan—Chills—Doxorubicin—breast cancer	0.000112	0.000214	CcSEcCtD
Frovatriptan—Arrhythmia—Doxorubicin—breast cancer	0.000111	0.000213	CcSEcCtD
Frovatriptan—Dizziness—Paclitaxel—breast cancer	0.00011	0.000212	CcSEcCtD
Frovatriptan—Mental disorder—Doxorubicin—breast cancer	0.000109	0.000209	CcSEcCtD
Frovatriptan—Ill-defined disorder—Epirubicin—breast cancer	0.000109	0.000208	CcSEcCtD
Frovatriptan—Abdominal pain—Capecitabine—breast cancer	0.000108	0.000208	CcSEcCtD
Frovatriptan—Body temperature increased—Capecitabine—breast cancer	0.000108	0.000208	CcSEcCtD
Frovatriptan—Convulsion—Methotrexate—breast cancer	0.000108	0.000208	CcSEcCtD
Frovatriptan—Malnutrition—Doxorubicin—breast cancer	0.000108	0.000207	CcSEcCtD
Frovatriptan—Agitation—Epirubicin—breast cancer	0.000108	0.000206	CcSEcCtD
Frovatriptan—Flatulence—Doxorubicin—breast cancer	0.000107	0.000204	CcSEcCtD
Frovatriptan—Myalgia—Methotrexate—breast cancer	0.000106	0.000204	CcSEcCtD
Frovatriptan—Arthralgia—Methotrexate—breast cancer	0.000106	0.000204	CcSEcCtD
Frovatriptan—Chest pain—Methotrexate—breast cancer	0.000106	0.000204	CcSEcCtD
Frovatriptan—Tension—Doxorubicin—breast cancer	0.000106	0.000204	CcSEcCtD
Frovatriptan—Vomiting—Paclitaxel—breast cancer	0.000106	0.000203	CcSEcCtD
Frovatriptan—Dysgeusia—Doxorubicin—breast cancer	0.000106	0.000203	CcSEcCtD
Frovatriptan—Malaise—Epirubicin—breast cancer	0.000106	0.000202	CcSEcCtD
Frovatriptan—Discomfort—Methotrexate—breast cancer	0.000105	0.000202	CcSEcCtD
Frovatriptan—Nervousness—Doxorubicin—breast cancer	0.000105	0.000201	CcSEcCtD
Frovatriptan—Vertigo—Epirubicin—breast cancer	0.000105	0.000201	CcSEcCtD
Frovatriptan—Syncope—Epirubicin—breast cancer	0.000105	0.000201	CcSEcCtD
Frovatriptan—Back pain—Doxorubicin—breast cancer	0.000105	0.000201	CcSEcCtD
Frovatriptan—Headache—Paclitaxel—breast cancer	0.000105	0.0002	CcSEcCtD
Frovatriptan—Hypersensitivity—Docetaxel—breast cancer	0.000104	0.0002	CcSEcCtD
Frovatriptan—Muscle spasms—Doxorubicin—breast cancer	0.000104	0.000199	CcSEcCtD
Frovatriptan—Palpitations—Epirubicin—breast cancer	0.000103	0.000198	CcSEcCtD
Frovatriptan—Confusional state—Methotrexate—breast cancer	0.000103	0.000197	CcSEcCtD
Frovatriptan—Loss of consciousness—Epirubicin—breast cancer	0.000103	0.000197	CcSEcCtD
Frovatriptan—Anaphylactic shock—Methotrexate—breast cancer	0.000102	0.000196	CcSEcCtD
Frovatriptan—Asthenia—Docetaxel—breast cancer	0.000102	0.000195	CcSEcCtD
Frovatriptan—Convulsion—Epirubicin—breast cancer	0.000101	0.000194	CcSEcCtD
Frovatriptan—Hypersensitivity—Capecitabine—breast cancer	0.000101	0.000194	CcSEcCtD
Frovatriptan—Ill-defined disorder—Doxorubicin—breast cancer	0.0001	0.000192	CcSEcCtD
Frovatriptan—Pruritus—Docetaxel—breast cancer	0.0001	0.000192	CcSEcCtD
Frovatriptan—Chest pain—Epirubicin—breast cancer	9.96e-05	0.000191	CcSEcCtD
Frovatriptan—Myalgia—Epirubicin—breast cancer	9.96e-05	0.000191	CcSEcCtD
Frovatriptan—Arthralgia—Epirubicin—breast cancer	9.96e-05	0.000191	CcSEcCtD
Frovatriptan—Agitation—Doxorubicin—breast cancer	9.95e-05	0.000191	CcSEcCtD
Frovatriptan—Anxiety—Epirubicin—breast cancer	9.93e-05	0.00019	CcSEcCtD
Frovatriptan—Nausea—Paclitaxel—breast cancer	9.92e-05	0.00019	CcSEcCtD
Frovatriptan—Hyperhidrosis—Methotrexate—breast cancer	9.87e-05	0.000189	CcSEcCtD
Frovatriptan—Discomfort—Epirubicin—breast cancer	9.84e-05	0.000189	CcSEcCtD
Frovatriptan—Asthenia—Capecitabine—breast cancer	9.84e-05	0.000188	CcSEcCtD
Frovatriptan—Malaise—Doxorubicin—breast cancer	9.76e-05	0.000187	CcSEcCtD
Frovatriptan—Dry mouth—Epirubicin—breast cancer	9.74e-05	0.000187	CcSEcCtD
Frovatriptan—Vertigo—Doxorubicin—breast cancer	9.73e-05	0.000186	CcSEcCtD
Frovatriptan—Anorexia—Methotrexate—breast cancer	9.73e-05	0.000186	CcSEcCtD
Frovatriptan—Syncope—Doxorubicin—breast cancer	9.71e-05	0.000186	CcSEcCtD
Frovatriptan—Pruritus—Capecitabine—breast cancer	9.7e-05	0.000186	CcSEcCtD
Frovatriptan—Diarrhoea—Docetaxel—breast cancer	9.69e-05	0.000186	CcSEcCtD
Frovatriptan—Confusional state—Epirubicin—breast cancer	9.63e-05	0.000184	CcSEcCtD
Frovatriptan—Palpitations—Doxorubicin—breast cancer	9.57e-05	0.000183	CcSEcCtD
Frovatriptan—Anaphylactic shock—Epirubicin—breast cancer	9.55e-05	0.000183	CcSEcCtD
Frovatriptan—Loss of consciousness—Doxorubicin—breast cancer	9.52e-05	0.000182	CcSEcCtD
Frovatriptan—Shock—Epirubicin—breast cancer	9.4e-05	0.00018	CcSEcCtD
Frovatriptan—Convulsion—Doxorubicin—breast cancer	9.38e-05	0.00018	CcSEcCtD
Frovatriptan—Diarrhoea—Capecitabine—breast cancer	9.38e-05	0.00018	CcSEcCtD
Frovatriptan—Dizziness—Docetaxel—breast cancer	9.36e-05	0.000179	CcSEcCtD
Frovatriptan—Tachycardia—Epirubicin—breast cancer	9.32e-05	0.000179	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Methotrexate—breast cancer	9.3e-05	0.000178	CcSEcCtD
Frovatriptan—Hyperhidrosis—Epirubicin—breast cancer	9.23e-05	0.000177	CcSEcCtD
Frovatriptan—Insomnia—Methotrexate—breast cancer	9.23e-05	0.000177	CcSEcCtD
Frovatriptan—Chest pain—Doxorubicin—breast cancer	9.22e-05	0.000177	CcSEcCtD
Frovatriptan—Arthralgia—Doxorubicin—breast cancer	9.22e-05	0.000177	CcSEcCtD
Frovatriptan—Myalgia—Doxorubicin—breast cancer	9.22e-05	0.000177	CcSEcCtD
Frovatriptan—Anxiety—Doxorubicin—breast cancer	9.19e-05	0.000176	CcSEcCtD
Frovatriptan—Paraesthesia—Methotrexate—breast cancer	9.16e-05	0.000176	CcSEcCtD
Frovatriptan—Discomfort—Doxorubicin—breast cancer	9.11e-05	0.000174	CcSEcCtD
Frovatriptan—Anorexia—Epirubicin—breast cancer	9.1e-05	0.000174	CcSEcCtD
Frovatriptan—Dyspnoea—Methotrexate—breast cancer	9.1e-05	0.000174	CcSEcCtD
Frovatriptan—Somnolence—Methotrexate—breast cancer	9.07e-05	0.000174	CcSEcCtD
Frovatriptan—Dizziness—Capecitabine—breast cancer	9.07e-05	0.000174	CcSEcCtD
Frovatriptan—Dry mouth—Doxorubicin—breast cancer	9.02e-05	0.000173	CcSEcCtD
Frovatriptan—Vomiting—Docetaxel—breast cancer	9e-05	0.000172	CcSEcCtD
Frovatriptan—Dyspepsia—Methotrexate—breast cancer	8.98e-05	0.000172	CcSEcCtD
Frovatriptan—Confusional state—Doxorubicin—breast cancer	8.91e-05	0.000171	CcSEcCtD
Frovatriptan—Decreased appetite—Methotrexate—breast cancer	8.87e-05	0.00017	CcSEcCtD
Frovatriptan—Headache—Docetaxel—breast cancer	8.87e-05	0.00017	CcSEcCtD
Frovatriptan—Anaphylactic shock—Doxorubicin—breast cancer	8.84e-05	0.000169	CcSEcCtD
Frovatriptan—Fatigue—Methotrexate—breast cancer	8.8e-05	0.000169	CcSEcCtD
Frovatriptan—Pain—Methotrexate—breast cancer	8.73e-05	0.000167	CcSEcCtD
Frovatriptan—Vomiting—Capecitabine—breast cancer	8.72e-05	0.000167	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Epirubicin—breast cancer	8.7e-05	0.000167	CcSEcCtD
Frovatriptan—Shock—Doxorubicin—breast cancer	8.69e-05	0.000167	CcSEcCtD
Frovatriptan—Insomnia—Epirubicin—breast cancer	8.64e-05	0.000165	CcSEcCtD
Frovatriptan—Tachycardia—Doxorubicin—breast cancer	8.62e-05	0.000165	CcSEcCtD
Frovatriptan—Headache—Capecitabine—breast cancer	8.59e-05	0.000165	CcSEcCtD
Frovatriptan—Paraesthesia—Epirubicin—breast cancer	8.58e-05	0.000164	CcSEcCtD
Frovatriptan—Hyperhidrosis—Doxorubicin—breast cancer	8.54e-05	0.000164	CcSEcCtD
Frovatriptan—Dyspnoea—Epirubicin—breast cancer	8.51e-05	0.000163	CcSEcCtD
Frovatriptan—Somnolence—Epirubicin—breast cancer	8.49e-05	0.000163	CcSEcCtD
Frovatriptan—Anorexia—Doxorubicin—breast cancer	8.42e-05	0.000161	CcSEcCtD
Frovatriptan—Nausea—Docetaxel—breast cancer	8.41e-05	0.000161	CcSEcCtD
Frovatriptan—Feeling abnormal—Methotrexate—breast cancer	8.41e-05	0.000161	CcSEcCtD
Frovatriptan—Dyspepsia—Epirubicin—breast cancer	8.41e-05	0.000161	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Methotrexate—breast cancer	8.35e-05	0.00016	CcSEcCtD
Frovatriptan—Decreased appetite—Epirubicin—breast cancer	8.3e-05	0.000159	CcSEcCtD
Frovatriptan—Fatigue—Epirubicin—breast cancer	8.23e-05	0.000158	CcSEcCtD
Frovatriptan—Constipation—Epirubicin—breast cancer	8.17e-05	0.000156	CcSEcCtD
Frovatriptan—Pain—Epirubicin—breast cancer	8.17e-05	0.000156	CcSEcCtD
Frovatriptan—Nausea—Capecitabine—breast cancer	8.14e-05	0.000156	CcSEcCtD
Frovatriptan—Abdominal pain—Methotrexate—breast cancer	8.07e-05	0.000155	CcSEcCtD
Frovatriptan—Body temperature increased—Methotrexate—breast cancer	8.07e-05	0.000155	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Doxorubicin—breast cancer	8.05e-05	0.000154	CcSEcCtD
Frovatriptan—Insomnia—Doxorubicin—breast cancer	7.99e-05	0.000153	CcSEcCtD
Frovatriptan—Paraesthesia—Doxorubicin—breast cancer	7.93e-05	0.000152	CcSEcCtD
Frovatriptan—Dyspnoea—Doxorubicin—breast cancer	7.88e-05	0.000151	CcSEcCtD
Frovatriptan—Feeling abnormal—Epirubicin—breast cancer	7.87e-05	0.000151	CcSEcCtD
Frovatriptan—Somnolence—Doxorubicin—breast cancer	7.86e-05	0.000151	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Epirubicin—breast cancer	7.81e-05	0.00015	CcSEcCtD
Frovatriptan—Dyspepsia—Doxorubicin—breast cancer	7.78e-05	0.000149	CcSEcCtD
Frovatriptan—Decreased appetite—Doxorubicin—breast cancer	7.68e-05	0.000147	CcSEcCtD
Frovatriptan—Fatigue—Doxorubicin—breast cancer	7.62e-05	0.000146	CcSEcCtD
Frovatriptan—Constipation—Doxorubicin—breast cancer	7.56e-05	0.000145	CcSEcCtD
Frovatriptan—Pain—Doxorubicin—breast cancer	7.56e-05	0.000145	CcSEcCtD
Frovatriptan—Abdominal pain—Epirubicin—breast cancer	7.55e-05	0.000145	CcSEcCtD
Frovatriptan—Body temperature increased—Epirubicin—breast cancer	7.55e-05	0.000145	CcSEcCtD
Frovatriptan—Hypersensitivity—Methotrexate—breast cancer	7.52e-05	0.000144	CcSEcCtD
Frovatriptan—Asthenia—Methotrexate—breast cancer	7.32e-05	0.00014	CcSEcCtD
Frovatriptan—Feeling abnormal—Doxorubicin—breast cancer	7.28e-05	0.00014	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Doxorubicin—breast cancer	7.23e-05	0.000138	CcSEcCtD
Frovatriptan—Pruritus—Methotrexate—breast cancer	7.22e-05	0.000138	CcSEcCtD
Frovatriptan—Hypersensitivity—Epirubicin—breast cancer	7.04e-05	0.000135	CcSEcCtD
Frovatriptan—Abdominal pain—Doxorubicin—breast cancer	6.99e-05	0.000134	CcSEcCtD
Frovatriptan—Body temperature increased—Doxorubicin—breast cancer	6.99e-05	0.000134	CcSEcCtD
Frovatriptan—Diarrhoea—Methotrexate—breast cancer	6.98e-05	0.000134	CcSEcCtD
Frovatriptan—Asthenia—Epirubicin—breast cancer	6.85e-05	0.000131	CcSEcCtD
Frovatriptan—Pruritus—Epirubicin—breast cancer	6.76e-05	0.000129	CcSEcCtD
Frovatriptan—Dizziness—Methotrexate—breast cancer	6.75e-05	0.000129	CcSEcCtD
Frovatriptan—Diarrhoea—Epirubicin—breast cancer	6.53e-05	0.000125	CcSEcCtD
Frovatriptan—Hypersensitivity—Doxorubicin—breast cancer	6.51e-05	0.000125	CcSEcCtD
Frovatriptan—Vomiting—Methotrexate—breast cancer	6.49e-05	0.000124	CcSEcCtD
Frovatriptan—Headache—Methotrexate—breast cancer	6.39e-05	0.000122	CcSEcCtD
Frovatriptan—Asthenia—Doxorubicin—breast cancer	6.34e-05	0.000121	CcSEcCtD
Frovatriptan—Dizziness—Epirubicin—breast cancer	6.32e-05	0.000121	CcSEcCtD
Frovatriptan—Pruritus—Doxorubicin—breast cancer	6.25e-05	0.00012	CcSEcCtD
Frovatriptan—Vomiting—Epirubicin—breast cancer	6.07e-05	0.000116	CcSEcCtD
Frovatriptan—Nausea—Methotrexate—breast cancer	6.06e-05	0.000116	CcSEcCtD
Frovatriptan—Diarrhoea—Doxorubicin—breast cancer	6.05e-05	0.000116	CcSEcCtD
Frovatriptan—Headache—Epirubicin—breast cancer	5.98e-05	0.000115	CcSEcCtD
Frovatriptan—Dizziness—Doxorubicin—breast cancer	5.84e-05	0.000112	CcSEcCtD
Frovatriptan—Nausea—Epirubicin—breast cancer	5.67e-05	0.000109	CcSEcCtD
Frovatriptan—Vomiting—Doxorubicin—breast cancer	5.62e-05	0.000108	CcSEcCtD
Frovatriptan—Headache—Doxorubicin—breast cancer	5.54e-05	0.000106	CcSEcCtD
Frovatriptan—Nausea—Doxorubicin—breast cancer	5.25e-05	0.000101	CcSEcCtD
Frovatriptan—HTR1A—Signaling Pathways—STAT5A—breast cancer	2.14e-05	0.000175	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP3—breast cancer	2.14e-05	0.000175	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTA1—breast cancer	2.14e-05	0.000175	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—IDH1—breast cancer	2.14e-05	0.000175	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CB—breast cancer	2.13e-05	0.000175	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KDR—breast cancer	2.13e-05	0.000174	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ESR1—breast cancer	2.12e-05	0.000173	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NAT2—breast cancer	2.11e-05	0.000173	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FN1—breast cancer	2.09e-05	0.000171	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ESR1—breast cancer	2.08e-05	0.00017	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SMAD4—breast cancer	2.07e-05	0.00017	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NFKBIA—breast cancer	2.07e-05	0.000169	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1R—breast cancer	2.06e-05	0.000169	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCL8—breast cancer	2.05e-05	0.000168	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FN1—breast cancer	2.05e-05	0.000168	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOTCH1—breast cancer	2.05e-05	0.000168	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NFKBIA—breast cancer	2.03e-05	0.000166	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HES1—breast cancer	2.02e-05	0.000166	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NCOR1—breast cancer	2.01e-05	0.000165	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PLA2G4A—breast cancer	2.01e-05	0.000165	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOTCH1—breast cancer	2.01e-05	0.000164	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APC—breast cancer	2e-05	0.000164	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CG—breast cancer	2e-05	0.000164	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KIT—breast cancer	2e-05	0.000164	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGF1—breast cancer	1.99e-05	0.000163	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CSF2—breast cancer	1.99e-05	0.000163	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—RAF1—breast cancer	1.99e-05	0.000162	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EGF—breast cancer	1.98e-05	0.000162	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NRG1—breast cancer	1.98e-05	0.000162	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CG—breast cancer	1.96e-05	0.000161	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APC—breast cancer	1.96e-05	0.000161	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KIT—breast cancer	1.96e-05	0.000161	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—H2AFX—breast cancer	1.96e-05	0.00016	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—IL2—breast cancer	1.96e-05	0.00016	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—E2F1—breast cancer	1.95e-05	0.000159	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EGF—breast cancer	1.94e-05	0.000159	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CB—breast cancer	1.94e-05	0.000159	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—MAPK3—breast cancer	1.92e-05	0.000157	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.91e-05	0.000156	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—BRAF—breast cancer	1.88e-05	0.000154	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—MAPK3—breast cancer	1.88e-05	0.000154	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SPP1—breast cancer	1.87e-05	0.000153	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCL8—breast cancer	1.86e-05	0.000152	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MED12—breast cancer	1.85e-05	0.000152	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—DPYD—breast cancer	1.85e-05	0.000152	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ERBB3—breast cancer	1.85e-05	0.000151	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGFR2—breast cancer	1.85e-05	0.000151	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—BRAF—breast cancer	1.84e-05	0.000151	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF1—breast cancer	1.83e-05	0.00015	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT2—breast cancer	1.83e-05	0.00015	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—EGFR—breast cancer	1.83e-05	0.000149	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALDOA—breast cancer	1.83e-05	0.000149	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF1—breast cancer	1.8e-05	0.000147	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT2—breast cancer	1.8e-05	0.000147	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—EGFR—breast cancer	1.79e-05	0.000146	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL2—breast cancer	1.78e-05	0.000146	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TERT—breast cancer	1.77e-05	0.000145	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NCOA3—breast cancer	1.77e-05	0.000145	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CD—breast cancer	1.76e-05	0.000144	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC2A2—breast cancer	1.76e-05	0.000144	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PIK3CA—breast cancer	1.74e-05	0.000143	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SERPINE1—breast cancer	1.74e-05	0.000143	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.74e-05	0.000142	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CD—breast cancer	1.72e-05	0.000141	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—KRAS—breast cancer	1.72e-05	0.000141	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CPT1A—breast cancer	1.72e-05	0.000141	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MTR—breast cancer	1.72e-05	0.000141	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCG2—breast cancer	1.72e-05	0.000141	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGFR1—breast cancer	1.72e-05	0.000141	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PIK3CA—breast cancer	1.71e-05	0.00014	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SERPINE1—breast cancer	1.71e-05	0.00014	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HIF1A—breast cancer	1.7e-05	0.000139	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HPGDS—breast cancer	1.69e-05	0.000138	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—KRAS—breast cancer	1.69e-05	0.000138	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HBA1—breast cancer	1.68e-05	0.000137	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOS3—breast cancer	1.66e-05	0.000136	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LEP—breast cancer	1.66e-05	0.000135	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CAV1—breast cancer	1.64e-05	0.000134	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTT1—breast cancer	1.64e-05	0.000134	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ACHE—breast cancer	1.64e-05	0.000134	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOS3—breast cancer	1.63e-05	0.000133	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KDR—breast cancer	1.62e-05	0.000133	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PIK3CA—breast cancer	1.58e-05	0.00013	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ESR1—breast cancer	1.58e-05	0.000129	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MDM2—breast cancer	1.58e-05	0.000129	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RAF1—breast cancer	1.57e-05	0.000129	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RELA—breast cancer	1.57e-05	0.000128	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FN1—breast cancer	1.56e-05	0.000128	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ERBB2—breast cancer	1.56e-05	0.000127	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP17A1—breast cancer	1.55e-05	0.000127	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3CA—breast cancer	1.55e-05	0.000127	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MDM2—breast cancer	1.55e-05	0.000126	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NFKBIA—breast cancer	1.54e-05	0.000126	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RAF1—breast cancer	1.54e-05	0.000126	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS1—breast cancer	1.54e-05	0.000126	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ENO1—breast cancer	1.54e-05	0.000126	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MTOR—breast cancer	1.54e-05	0.000126	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CB—breast cancer	1.54e-05	0.000126	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RELA—breast cancer	1.53e-05	0.000125	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.53e-05	0.000125	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOTCH1—breast cancer	1.53e-05	0.000125	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ERBB2—breast cancer	1.52e-05	0.000125	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.51e-05	0.000124	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP2D6—breast cancer	1.51e-05	0.000123	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MTOR—breast cancer	1.5e-05	0.000123	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CB—breast cancer	1.5e-05	0.000123	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APC—breast cancer	1.49e-05	0.000122	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CG—breast cancer	1.49e-05	0.000122	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KIT—breast cancer	1.49e-05	0.000122	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NCOA2—breast cancer	1.48e-05	0.000121	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EGF—breast cancer	1.48e-05	0.000121	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCL8—breast cancer	1.48e-05	0.000121	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HRAS—breast cancer	1.47e-05	0.00012	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL8—breast cancer	1.44e-05	0.000118	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CDKN1B—breast cancer	1.44e-05	0.000118	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HRAS—breast cancer	1.44e-05	0.000117	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—FASN—breast cancer	1.43e-05	0.000117	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—MAPK3—breast cancer	1.43e-05	0.000117	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—BCHE—breast cancer	1.43e-05	0.000117	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—AKT1—breast cancer	1.43e-05	0.000117	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CASP3—breast cancer	1.41e-05	0.000116	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC5A5—breast cancer	1.41e-05	0.000115	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CDKN1B—breast cancer	1.41e-05	0.000115	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL2—breast cancer	1.41e-05	0.000115	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—BRAF—breast cancer	1.4e-05	0.000115	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—breast cancer	1.4e-05	0.000115	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—AKT1—breast cancer	1.4e-05	0.000114	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CASP3—breast cancer	1.38e-05	0.000113	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL2—breast cancer	1.38e-05	0.000113	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCND1—breast cancer	1.37e-05	0.000112	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—breast cancer	1.37e-05	0.000112	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—JUN—breast cancer	1.37e-05	0.000112	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1—breast cancer	1.37e-05	0.000112	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT2—breast cancer	1.37e-05	0.000112	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC2A1—breast cancer	1.36e-05	0.000111	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NQO1—breast cancer	1.36e-05	0.000111	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—EGFR—breast cancer	1.36e-05	0.000111	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CTNNB1—breast cancer	1.36e-05	0.000111	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCND1—breast cancer	1.35e-05	0.00011	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—JUN—breast cancer	1.34e-05	0.00011	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MMP9—breast cancer	1.33e-05	0.000109	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.33e-05	0.000109	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CTNNB1—breast cancer	1.33e-05	0.000109	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CDKN1A—breast cancer	1.33e-05	0.000109	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP3A4—breast cancer	1.33e-05	0.000109	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PTEN—breast cancer	1.33e-05	0.000109	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.32e-05	0.000108	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CD—breast cancer	1.31e-05	0.000107	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MMP9—breast cancer	1.31e-05	0.000107	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP1B1—breast cancer	1.31e-05	0.000107	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CDKN1A—breast cancer	1.3e-05	0.000107	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CA—breast cancer	1.3e-05	0.000106	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SERPINE1—breast cancer	1.3e-05	0.000106	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PTEN—breast cancer	1.3e-05	0.000106	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK8—breast cancer	1.3e-05	0.000106	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AKT1—breast cancer	1.29e-05	0.000106	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—KRAS—breast cancer	1.29e-05	0.000105	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.28e-05	0.000105	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK8—breast cancer	1.27e-05	0.000104	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AKT1—breast cancer	1.27e-05	0.000104	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NCOA1—breast cancer	1.25e-05	0.000102	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOS3—breast cancer	1.24e-05	0.000101	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SRC—breast cancer	1.23e-05	0.000101	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—STK11—breast cancer	1.23e-05	0.0001	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP19A1—breast cancer	1.23e-05	0.0001	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SRC—breast cancer	1.2e-05	9.86e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—VEGFA—breast cancer	1.2e-05	9.8e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—STAT3—breast cancer	1.19e-05	9.71e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	1.18e-05	9.67e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MDM2—breast cancer	1.18e-05	9.63e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—VEGFA—breast cancer	1.17e-05	9.6e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RAF1—breast cancer	1.17e-05	9.6e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RELA—breast cancer	1.17e-05	9.55e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—STAT3—breast cancer	1.16e-05	9.5e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ERBB2—breast cancer	1.16e-05	9.49e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.15e-05	9.43e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MTOR—breast cancer	1.15e-05	9.37e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CB—breast cancer	1.15e-05	9.37e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—COMT—breast cancer	1.14e-05	9.34e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTP1—breast cancer	1.14e-05	9.3e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK3—breast cancer	1.13e-05	9.27e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMOX1—breast cancer	1.12e-05	9.17e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ITPR1—breast cancer	1.12e-05	9.15e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK3—breast cancer	1.11e-05	9.08e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MYC—breast cancer	1.1e-05	9.02e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL8—breast cancer	1.1e-05	9e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TGFB1—breast cancer	1.1e-05	9e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HRAS—breast cancer	1.09e-05	8.94e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MYC—breast cancer	1.08e-05	8.83e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EGFR—breast cancer	1.08e-05	8.82e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TGFB1—breast cancer	1.08e-05	8.81e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCB1—breast cancer	1.08e-05	8.8e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CDKN1B—breast cancer	1.07e-05	8.79e-05	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT1—breast cancer	1.06e-05	8.7e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TYMS—breast cancer	1.06e-05	8.64e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EGFR—breast cancer	1.06e-05	8.64e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CASP3—breast cancer	1.05e-05	8.62e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL2—breast cancer	1.05e-05	8.6e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—breast cancer	1.05e-05	8.56e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTM1—breast cancer	1.04e-05	8.54e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NCOR1—breast cancer	1.04e-05	8.54e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.04e-05	8.54e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCND1—breast cancer	1.03e-05	8.39e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—JUN—breast cancer	1.02e-05	8.37e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KRAS—breast cancer	1.02e-05	8.33e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CTNNB1—breast cancer	1.02e-05	8.31e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GPX1—breast cancer	1e-05	8.18e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KRAS—breast cancer	9.97e-06	8.16e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP9—breast cancer	9.95e-06	8.14e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CDKN1A—breast cancer	9.92e-06	8.11e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP1A1—breast cancer	9.9e-06	8.1e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTEN—breast cancer	9.9e-06	8.1e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ERCC2—breast cancer	9.82e-06	8.03e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK8—breast cancer	9.68e-06	7.92e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT1—breast cancer	9.65e-06	7.9e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CA—breast cancer	9.36e-06	7.66e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MTHFR—breast cancer	9.23e-06	7.55e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SRC—breast cancer	9.18e-06	7.51e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CA—breast cancer	9.16e-06	7.5e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TP53—breast cancer	9.05e-06	7.41e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VEGFA—breast cancer	8.94e-06	7.31e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TP53—breast cancer	8.87e-06	7.25e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—STAT3—breast cancer	8.85e-06	7.24e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HRAS—breast cancer	8.66e-06	7.08e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CAV1—breast cancer	8.51e-06	6.97e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HRAS—breast cancer	8.48e-06	6.94e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK3—breast cancer	8.46e-06	6.92e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—breast cancer	8.29e-06	6.78e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MYC—breast cancer	8.22e-06	6.73e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFB1—breast cancer	8.2e-06	6.71e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.13e-06	6.65e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—breast cancer	8.11e-06	6.64e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EGFR—breast cancer	8.04e-06	6.58e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CG—breast cancer	7.75e-06	6.34e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT1—breast cancer	7.65e-06	6.26e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KRAS—breast cancer	7.6e-06	6.22e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT1—breast cancer	7.49e-06	6.12e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CA—breast cancer	6.98e-06	5.71e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CD—breast cancer	6.82e-06	5.58e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TP53—breast cancer	6.75e-06	5.53e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALB—breast cancer	6.73e-06	5.51e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HRAS—breast cancer	6.46e-06	5.28e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NOS3—breast cancer	6.44e-06	5.27e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—breast cancer	6.18e-06	5.06e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CB—breast cancer	5.94e-06	4.86e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS2—breast cancer	5.89e-06	4.82e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT1—breast cancer	5.7e-06	4.67e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTEN—breast cancer	5.13e-06	4.2e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CA—breast cancer	3.62e-06	2.96e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKT1—breast cancer	2.96e-06	2.42e-05	CbGpPWpGaD
